LLY FY 2015 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

FY 2015 Earnings

Reported February 19, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2015	Prior Q	FY 2014	QoQ Change	YoY Change
Revenue	$20.0B	—	$19.6B	—	1.7%
Op. Income	$3.6B	—	$3.3B	—	7.9%
Gross Margin	74.8%	—	74.9%	—	-0.1pp
Net Margin	12.1%	—	12.2%	—	-0.1pp
EPS (Diluted)	$2.18	—	$2.15	—	1.4%
Free Cash Flow	$1.3B	—	$2.9B	—	-53.7%

Revenue Flow

Item	Amount
REVENUE	$20.0B
Cost of Revenue	$5.0B
GROSS PROFIT	$14.9B
R&D Expenses	$4.8B
Selling & Marketing	$0
General & Administrative	$6.5B
SG&A Expenses	$6.5B
Other Expenses	$0
Operating Expenses	$11.3B
Cost & Expenses	$16.4B
OPERATING INCOME	$3.6B
Interest Income	$87M
Interest Expense	$161M
Other Income/Expenses	-$802M
INCOME BEFORE TAX	$2.8B
Income Tax Expense	$382M
Net Income from Continuing Ops	$2.4B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$2.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.4B
D&A	$1.4B
EBIT	$3.0B
EBITDA	$4.4B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$20.0B
Cost of Revenue	$5.0B
GROSS PROFIT	$14.9B
R&D Expenses	$4.8B
Selling & Marketing	$0
General & Administrative	$6.5B
SG&A Expenses	$6.5B
Other Expenses	$0
Operating Expenses	$11.3B
Cost & Expenses	$16.4B
OPERATING INCOME	$3.6B
Interest Income	$87M
Interest Expense	$161M
Other Income/Expenses	-$802M
INCOME BEFORE TAX	$2.8B
Income Tax Expense	$382M
Net Income from Continuing Ops	$2.4B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$2.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.4B
D&A	$1.4B
EBIT	$3.0B
EBITDA	$4.4B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$2.4B
Depreciation & Amortization	$1.4B
Stock-Based Compensation	$218M
Deferred Income Tax	-$748M
Other Non-Cash Items	$798M
Change in Working Capital	-$1.1B
OPERATING CASH FLOW	$3.0B
Capital Expenditure	-$1.6B
Acquisitions (Net)	-$5.3B
Purchases of Investments	-$4.1B
Sales/Maturities of Investments	$5.2B
Other Investing Activities	$5.8B
NET CASH FROM INVESTING	$27M
Net Debt Issuance	-$182M
Common Stock Repurchased	-$750M
Common Dividends Paid	-$2.1B
Other Financing Activities	$139M
NET CASH FROM FINANCING	-$2.9B
FREE CASH FLOW	$1.3B
Net Change in Cash	-$205M

Balance Sheet

Item	Amount
Cash & Equivalents	$3.7B
Short-Term Investments	$785M
Net Receivables	$4.1B
Inventory	$3.4B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$12.6B
PP&E (Net)	$8.1B
Goodwill	$4.0B
Intangible Assets	$5.0B
Long-Term Investments	$3.6B
Tax Assets	$0
Other Non-Current Assets	$2.2B
TOTAL NON-CURRENT ASSETS	$23.0B
TOTAL ASSETS	$35.6B
Account Payables	$1.3B
Short-Term Debt	$6M
Deferred Revenue	$0
Other Current Liabilities	$3.4B
TOTAL CURRENT LIABILITIES	$8.2B
Long-Term Debt	$8.0B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$4.8B
TOTAL NON-CURRENT LIABILITIES	$12.7B
TOTAL LIABILITIES	$21.0B
Common Stock	$691M
Additional Paid-In Capital	$5.6B
Retained Earnings	$16.0B
Treasury Stock	-$90M
Accum. Other Comp. Income	-$4.6B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$14.6B
Minority Interest	$19M
TOTAL EQUITY	$14.6B
TOTAL LIABILITIES & EQUITY	$35.6B
Total Debt	$8.0B
Net Debt	$4.3B